Skip to content

Piloting a Healthy Aging Cohort in Manitoba

Piloting a Healthy Aging Cohort in Manitoba - PACMan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06100224
Acronym
PACMan
Enrollment
80
Registered
2023-10-25
Start date
2024-04-01
Completion date
2026-07-01
Last updated
2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Aging

Keywords

Medical fitness facility

Brief summary

The purpose of this study is to set up and pilot baseline and year 1 data collection for a prospective cohort designed to explore the relationships between medical fitness facility usage, lifestyle behaviours and health outcomes as individuals age. Additionally, this pilot study will set up the overall objectives for the larger, prospective cohort study using a public engagement participatory approach with public/patient partners involved in determining which healthy aging outcomes to include.

Detailed description

This project will cover the set-up, development, and user-testing of the baseline visit data collection in the first 100 participants. Data will be collected on physical activity, diet, sleep, stress, cognition, frailty, health history (including diabetes, alcohol and smoking), facility and program usage at the Wellness Institute (WI), height, weight, volitional oxygen intake (VO2 max), blood pressure, heart rate, clinical chemistry, urinalysis, body composition, social determinants of health, and wellbeing. Additionally, a public engagement participatory approach will be used to determine which healthy aging outcomes are important to study, including discussion on research priorities, research question, research design, data collection approaches, outcome measures, analysis of results, relevance of findings, and dissemination of findings. Therefore, this pilot project will include the formation of a project advisory group that will include public/patient partners. The advisory group members will discuss ideas around healthy aging and lifestyle and what outcomes are most important to them; and will provide information on the reasons for joining as well as the use of the medical fitness facility, any barriers they face and program needs. The project advisory group will be an integral part of this pilot project. The information obtained from the advisory group meetings and the pilot project will be used to develop the outcomes for the larger cohort study.

Interventions

None listed

Sponsors

University of Manitoba
Lead SponsorOTHER
Seven Oaks Hospital Chronic Disease Innovation Centre
CollaboratorNETWORK
The Wellness Institute Powered by Seven Oaks General Hospital
CollaboratorUNKNOWN
Medical Fitness Association
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Individuals, aged 30 years or older at the time of signing the informed consent * Able to communicate in English and provide written informed consent * Current member of the Wellness Institute * Access to a device such as an android or iOS smartphone or tablet for use with the dietary tracking application.

Exclusion criteria

* Female participant who is pregnant or lactating * Employees of the Wellness Institute * Involvement in the planning and/or conduct of the study

Design outcomes

Primary

MeasureTime frameDescription
Health HistoryAt baseline and Year 1Collected using the Chronic Conditions, Health History and Facility Usage Questionnaire and the Family Medical History Questionnaire
Fitness LevelAt baseline and Year 1Measured by volitional oxygen intake, otherwise known as VO2 max, using the Ebbeling Treadmill Test (a submaximal walking test)
DietAt Baseline and Year 1Measured using the Mindful Eating Questionnaire and the 3 Factor Eating Questionnaire
Dietary IntakeAt Baseline and Year 1The RxFood App will be used to measure dietary intake over 3 full days.
Physical ActivityAt Baseline and Year 1Measured using the International Physical Activity Questionnaire - Short form (IPAQ-S)
Physical Activity AssessmentAt Baseline and Year 1An Actigraph activity monitor will be used to measure physical activity for 7 days, wtih participants asked to wear the monitor at all times.
Sleep Quality AssessmentAt Baseline and Year 1Measured using the Pittsburgh Sleep Quality Index Questionnaire (PSQI), an effective instrument used to measure the quality and patterns of sleep in adults. It differentiates "poor" from "good" sleep quality by measuring seven areas (components): subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medications, and daytime dysfunction.
Sleep AssessmentAt Baseline and Year 1An ActiGraph activity monitor will be used to measure sleep quality patterns for 7 days, wtih participants asked to wear the monitor at all times, including when they sleep.
StressAt Baseline and Year 1The Perceived Stress Questionnaire (PSQ) will be completed to assess stressful life events and circumstances that tend to trigger or exacerbate disease symptoms.
Cognition AssessmentAt Baseline and Year 1The Montreal Cognitive Assessment Score (MoCA) will be used to give insight into how participants mentally process information.
Body WeightAt Baseline and Year 1Body weight will be measured.
Body Mass Index (BMI)At Baseline and Year 1Body Mass Index will be measured
Waist circumferenceAt Baseline and Year 1Waist circumference will be measured
Blood PressureAt Baseline and Year 1Blood pressure while awake, while asleep, and total will be measured using an ambulatory blood pressure monitor, worn for 3 consecutive days.
FrailtyAt Baseline and Year 1The Short Physical Performance Battery (balance test, gait speed, and chair stand) and handgrip strength with be collected to measure frailty.
Facility UsageAt Baseline and Year 1Participants will complete a questionnaire on attendance in hours per week, and # of times per week, and specific program/facility usage at the Wellness Institute. The Wellness Institute swipe data will be used to record the number of times swiped per week and per month since joining.
CholesterolAt Baseline and Year 1Total cholesterol, HDL-C, LDL-C, triglycerides, total cholesterol/HDL ratio
HbA1cAt Baseline and Year 1Hemoglobin A1C
eGFRAt Baseline and Year 1Estimated glomerular filtration rate.
uACRAt Baseline and Year 1Urine albumin to creatinine ratio
10-Year Risk of Cardiovascular DiseaseAt Baseline and Year 1Measured using the Framingham Risk Score
Cardiovascular AssessmentAt Baseline and Year 1Identification of Metabolic Syndrome and the Framingham Risk Score will be measured.
Body CompositionAt Baseline and Year 1DEXA scan measurements including total mass, fat mass, lean mass, % fat, visceral adipose tissue, total body bone mineral density), and relative skeletal muscle index (RSMI) will be collected.
Social Determinants of HealthAt Baseline and Year 1Access to general medical and dental care, postal code, household income, education level and marital status will be collected.
Wellbeing - Quality of LifeAt Baseline and Year 1the EQ-5D-5L will be collected to measure quality of life.
Wellbeing - LonelinessAt Baseline and Year 1The UCLA Loneliness Scale will be sued to measure loneliness.
Wellbeing - Life SatisfactionAt Baseline and Year 1The Satisfaction With Life Scale will be used to measure life satisfaction
Wellbeing - Self-efficacyAt Baseline and Year 1The Multidimensional Health Locus of Control (MHLC) Scale Form A will be used to measure self-efficacy
Wellbeing - DepressionAt Baseline and Year 1The Center for Epidemiologic Studies Short Depression Scale (CES-D-10) will be used to measure depression

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORClaudio Rigatto, MD

University of Manitoba

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 26, 2026